Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: Ibuprofen restores its motor activity

Journal of Neuroscience Research

Volumn 87, Issue 6, 2009, Pages 1369-1374

  Cauli, Omar ^a   Rodrigo, Regina ^a   Piedrafita, Blanca ^a   Llansola, Martha ^a   Mansouri, Mohammad T ^a   Felipo, Vicente ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

Glutamate transporters; Hepatic encephalopathy; Hypokinesia; Neuro inflammation; Substantia nigra

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMIC ACID; IBUPROFEN; VESICULAR GLUTAMATE TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HEPATIC ENCEPHALOPATHY; HYPOKINESIA; MALE; MOTOR ACTIVITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PORTOCAVAL SHUNT; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; EXTRACELLULAR SPACE; IMMUNOBLOTTING; INFLAMMATION; METABOLISM; MICRODIALYSIS; PATHOPHYSIOLOGY; SUBSTANTIA NIGRA;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; EXTRACELLULAR SPACE; GLUTAMIC ACID; HEPATIC ENCEPHALOPATHY; HYPOKINESIA; IBUPROFEN; IMMUNOBLOTTING; INFLAMMATION; MALE; MICRODIALYSIS; MOTOR ACTIVITY; RATS; SUBSTANTIA NIGRA;

EID: 65549166426     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21947     Document Type: Article

References (24)

1. Amodio P, Montagnese S, Gatta A, Morgan MY. 2004. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19:253-267.
2. Bengtsson F, Nobin A, Falck B, Gage FH, Jeppsson B. 1986. Portacaval shunt in the rat: selective alterations in behavior and brain serotonin. Pharmacol Biochem Behav 24:1611-1616.
3. Canales JJ, Elayadi A, Errami M, Llansola M, Cauli O, Felipo V. 2003. Chronic hyperammonemia alters motor and neurochemical responses to activation of group I metabotropic glutamate receptors in the nucleus accumbens in rats in vivo. Neurobiol Dis 14:380-390.
4. Cauli O, Llansola M, Erceg S, Felipo V. 2006. Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J Hepatol 45:654-661.
5. Cauli O, Mlili N, Llansola M, Felipo V. 2007a. Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats. Eur J Neurosci 25:2112-2122.
6. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. 2007b. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portocaval shunts. Hepatology 46:514-519.
7. Chung C, Gottstein J, Blei AT. 2001. Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 34:249-254.
8. Felipo V, Grau E, Miñana MD, Grisolía S. 1993. Ammonium injection induces an N-methyl-D-aspartate receptor mediated proteolysis of the microtubule associated protein MAP 2. J Neurochem 60:1626-1630.
9. Jover R, Company L, Gutierrez A, Lorente M, Zapater P, Povedam MJ, et al. 2005. Clinical significance of extrapyramidal signs in patients with cirrhosis. J Hepatol 42:659-665.
10. Lee SH, Fisher B. 1961. Portacaval shunt in the rat. Surgery 50:668-672.
11. Martin JR. 1986. Discordant motor activity levels of portacaval-shunted rats in runway and swim tests. Behav Neurosci 100:427-437.
12. + dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress. Brain Res 922:21-29.
13. Monfort P, Muñoz MD, ElAyadi A, Kosenko E, Felipo V. 2002. Effects of hyperammonemia and liver disease on glutamatergic neurotransmission. Metab Brain Dis 17:237-250.
14. Paxinos G, Watson C. 1996. The rat brain in stereotaxic coordinates. New York: Academic Press.
15. Shawcross DL, Davies NA, Williams R, Jalan R. 2004. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40:247-254.
16. Sitcheran R, Gupta P, Fisher PB, Baldwin AS. 2005. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNF alpha-controlled repression. EMBO J 24:510-520.
17. Song G, Dhodda VK, Blei AT, Dempsey RJ, Rao VL. 2002. GeneChip analysis shows altered mRNA expression of transcripts of neurotransmitter and signal transduction pathways in the cerebral cortex of portacaval shunted rats. J Neurosci Res 68:730-737.
18. Steindl PE, Coy DL, Finn B, Zee PC, Blei AT. 1996. A low-protein diet ameliorates disrupted diurnal locomotor activity in rats after portacaval anastomosis. Am J Physiol 271:G555-G560.
19. Szymocha R, Akaoka H, Dutuit M, Malcus C, Didier-Bazes M, Belinm MF, Giraudon P. 2000. Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J Virol 74:6433-6441.
20. Theander B, Apelqvist G, Bugge M, Andersson G, Hindfelt B, Bengtsson F. 1996. Gender and diurnal effects on specific open-field behavioral patterns in the portacaval shunted rat. Metab Brain Dis 12:47-59.
21. Tilleux S, Hermans E. 2007. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85:2059-2070.
22. Timmermann L, Gross J, Butz M, Kircheis G, Haussinger D, Schnitzler A. 2003. Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling. Neurology 61:689-692.
23. Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, Rothstein JD, Volsky DJ. 2003. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 312:60-73.
24. Weissenborn K, Kolbe H. 1998. The basal ganglia and portal-systemic encephalopathy. Metab Brain Dis 13:261-272.